Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Bobulsky SusanChief Commercial Officer, MRD | Open-market sale · 10b5-1 plan | SELL | $75K 3,000 sh |
| Aug 12, 2026 traded Aug 10, 2026 |
| 4 | Tsao DavidDirector, Chief Technology Officer | Option exercise · 10b5-1 plan | M | $28K 10.0K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 3 | Knopp Kevin J.Director, President and CEO | Open-market sale · 10b5-1 plan | SELL | $28K 2,747 sh | Aug 12, 2026 traded Aug 12, 2026 |
| 2 | Trigg William ShaneDirector, Chief Executive Officer | Tax withholding | F | $44K 219 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 2 | Eaton Timothy MathiasChief Financial Officer | Tax withholding | F | $5,587 28 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 2 | Eaton Timothy MathiasChief Financial Officer | Tax withholding | F | $6,984 35 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 2 | Eaton Timothy MathiasChief Financial Officer | Tax withholding | F | $8,181 41 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 2 | Eaton Timothy MathiasChief Financial Officer | Tax withholding | F | $32K 160 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 2 | Eaton Timothy MathiasChief Financial Officer | Tax withholding | F | $34K 170 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 2 | Eaton Timothy MathiasChief Financial Officer | Tax withholding | F | $15K 75 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 2 | Trigg William ShaneDirector, Chief Executive Officer | Tax withholding | F | $40K 202 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 2 | Eaton Timothy MathiasChief Financial Officer | Tax withholding | F | $25K 125 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 1 | Pieper StevenSee Remarks | Open-market sale · 10b5-1 plan | SELL | $43K 5,000 sh | Aug 12, 2026 traded Aug 12, 2026 |
| 1 | Prahm JeremyChief Investment Officer | Open-market sale · 10b5-1 plan | SELL | $130K 6,000 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 1 | Phillips Ronald LEVP and CHRO | Open-market sale · 10b5-1 plan | SELL | $31K 367 sh | Aug 12, 2026 traded Aug 11, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 2,170 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Silbermann BenjaminDirector, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 46.9K sh | Aug 12, 2026 traded Aug 12, 2026 |
| 0 | Pickering EvanGeneral Counsel | Tax withholding · 10b5-1 plan | F | $7,782 39 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Chandhok NikhilChief Product & Tech. Officer | Option exercise · 10b5-1 plan | M | $602K 23.3K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Pickering EvanGeneral Counsel | Tax withholding · 10b5-1 plan | F | $16K 80 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Silbermann BenjaminDirector, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 46.9K sh | Aug 12, 2026 traded Aug 11, 2026 |
| 0 | Walsh Mark T.Director, CEO & Director | Option exercise · 10b5-1 plan | M | $71K 50.0K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 25.0K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | $35K 2,170 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 12.5K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Walsh Mark T.Director, CEO & Director | Option exercise · 10b5-1 plan | M | $158K 50.0K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Doyle MittieChief Medical Officer | Option exercise · 10b5-1 plan | M | — 679 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 25.0K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Walsh Mark T.Director, CEO & Director | Option exercise · 10b5-1 plan | M | $59K 42.1K sh | Aug 12, 2026 traded Aug 11, 2026 |
| 0 | Silbermann BenjaminDirector, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 46.9K sh | Aug 12, 2026 traded Aug 11, 2026 |
| 0 | Pickering EvanGeneral Counsel | Tax withholding · 10b5-1 plan | F | $5,388 27 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Pickering EvanGeneral Counsel | Tax withholding · 10b5-1 plan | F | $11K 54 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Colburn Richard Edward IIIChief Product & Tech Officer | Option exercise · 10b5-1 plan | M | — 1,229 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Tsao DavidDirector, Chief Technology Officer | Option exercise · 10b5-1 plan | M | $28K 10.0K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Chandhok NikhilChief Product & Tech. Officer | Option exercise · 10b5-1 plan | M | — 23.3K sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Rigler DonPrincipal Accounting Officer | Tax withholding · 10b5-1 plan | F | $12K 62 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Phillips Ronald LEVP and CHRO | Tax withholding · 10b5-1 plan | F | $80K 953 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | McBee BranninChief Development Officer | Derivative conversion · 10b5-1 plan | C | — 3,000 sh | Aug 12, 2026 traded Aug 10, 2026 |
| 0 | Doyle MittieChief Medical Officer | Option exercise · 10b5-1 plan | M | $5,459 679 sh | Aug 12, 2026 traded Aug 10, 2026 |